MetaSight Diagnostics

MetaSight Diagnostics is a pioneering health technology company dedicated to revolutionizing early disease detection through affordable and precise liquid biopsy diagnostics. Leveraging proprietary and cost-effective mass spectrometry technologies, including metabolomics, lipidomics, and proteomics, MetaSight Diagnostics is at the forefront of innovation in medical diagnostics.

Located at 2 Holzman st. Rehovot, IL, MetaSight Diagnostics has established the world's largest and most comprehensive serum metabolomics dataset linked with Electronic Health Records, and is expanding into additional omics. This unique platform empowers a team of experts in analytical chemistry, artificial intelligence, and medicine to develop and commercialize cutting-edge diagnostic products aimed at significantly improving human health outcomes. MetaSight Diagnostics is committed to advancing healthcare through groundbreaking research and development.

MetaSight Diagnostics is poised for continued growth and success in the medical and diagnostic laboratories sector. MetaSight Diagnostics is committed to delivering impactful solutions that address critical healthcare challenges. We invite the manager of MetaSight Diagnostics to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative contributions.